United States · 
Who invested in Eradivir?
Eradivir's investors include National Science Foundation.
2025
$9.8MSeries A$10MVenture
United States · Venture startup
Who invested in Eradivir
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2024, from 2 sources
$9.8MSeries A$10MVenture
- Latest round
- Venture, $10MOct 2025
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $9.8M Sept 2024
- Biggest round
- $10M Venture · Oct 2025
- Between rounds
- 13 months from the last two
The rounds
- Oct 2025
- Sept 2024
Founders and team
From Eradivir's own website: 2 on the team.
- Martin LowChief Executive Officer
- Aaron BlouinSenior Director Clinical Operations
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Eradivir as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Eradivir
How much has Eradivir raised?
Eradivir has raised $20M across 2 rounds since 2024.
When did Eradivir last raise?
Eradivir's most recent round was a Venture of $10M in Oct 2025.
What was Eradivir's biggest round?
Its most recent round, $10M in Oct 2025, is also its largest on record.
Who backed Eradivir first?
Eradivir's first round on record, in Sept 2024, was backed by National Science Foundation.
What stage is Eradivir at?
Eradivir's latest named round is a Venture, in Oct 2025.
Where is Eradivir based?
Eradivir is based in the United States.
Companies like Eradivir
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.